Schering-Plough Corp. is pursuing patent infringement actions
against companies seeking approval of generic versions of Clarinex
Tablets, Clarinex Reditabs and Clarinex D12.
The Company filed these actions in September 2006. (Lloyds…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.